- Home
- GDV vs BHC Comparison
GDV vs BHC Comparison
Compare GDV & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- BHC
- Stock Information
- Founded
- GDV 2003
- BHC N/A
- Country
- GDV United States
- BHC Canada
- Employees
- GDV N/A
- BHC N/A
- Industry
- GDV Investment Managers
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- BHC Health Care
- Exchange
- GDV Nasdaq
- BHC Nasdaq
- Market Cap
- GDV 2.3B
- BHC 2.6B
- IPO Year
- GDV N/A
- BHC N/A
- Fundamental
- Price
- GDV $24.15
- BHC $6.47
- Analyst Decision
- GDV
- BHC Hold
- Analyst Count
- GDV 0
- BHC 5
- Target Price
- GDV N/A
- BHC $7.20
- AVG Volume (30 Days)
- GDV 186.0K
- BHC 1.4M
- Earning Date
- GDV 01-01-0001
- BHC 04-30-2025
- Dividend Yield
- GDV 5.81%
- BHC N/A
- EPS Growth
- GDV N/A
- BHC N/A
- EPS
- GDV N/A
- BHC N/A
- Revenue
- GDV N/A
- BHC $9,625,000,000.00
- Revenue This Year
- GDV N/A
- BHC $4.76
- Revenue Next Year
- GDV N/A
- BHC $2.05
- P/E Ratio
- GDV N/A
- BHC N/A
- Revenue Growth
- GDV N/A
- BHC 9.91
- 52 Week Low
- GDV $18.04
- BHC $3.96
- 52 Week High
- GDV $23.00
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- GDV 45.99
- BHC 35.56
- Support Level
- GDV $23.95
- BHC $6.91
- Resistance Level
- GDV $24.59
- BHC $7.45
- Average True Range (ATR)
- GDV 0.28
- BHC 0.27
- MACD
- GDV 0.07
- BHC -0.05
- Stochastic Oscillator
- GDV 61.40
- BHC 2.00
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food & Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.